ascopubs.org

New safety and efficacy data of the ongoing phase I/II study (ASET Study) with an allogeneic tumor vaccine and adjuvant in patients with metastatic renal cell carcinoma.

Use of R.E.N.A.L. nephrometry scoring system to predict the functional efficacy of nephron-sparing surgery in the solitary kidney. Background: The purpose of this first-in-man phase 1-2 study is to ...
ascopubs.org

Efficacy and safety of cancer vaccine with 4-fold gene-modified allogeneic tumor cells: Results of the phase I/II ASET study in patients with advanced renal cell carcinoma.

Genetic polymorphisms’ influence in outcome of metastatic renal cell cancer patients treated with VEGF-targeted agents. Longitudinal serum testosterone levels (T) in long-term testicular cancer ...